Entering text into the input field will update the search result below

Lexicon Pharmaceuticals Q1 net loss worsens 24%

  • Lexicon Pharmaceuticals (NASDAQ:LXRX -8.4%) Q1 results: Revenues: $12.5M; R&D Expense: $37M (+77.0%); SG&A: $8.4M (+47.4%); Operating Loss: ($33.9M) (-27.9%); Net Loss: ($34.9M) (-24.2%); Loss Per Share: ($0.34) (-25.9%); Quick Assets: $477.1M (-8.5%).
  • No guidance given.

Recommended For You

More Trending News

About LXRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
LXRX--
Lexicon Pharmaceuticals, Inc.